一、监事会会议召开情况 证券代码：001388 证券简称：信通电子 公告编号：2025-009 山东信通电子股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 山东信通电子股份有限公司（以下简称"公司"）第四届监事会第十一次会议于 方式送达各位监事。本次会议应出席监事3名，实际出席监事3名。本次会议由监事会 主席崔利先生召集并主持，公司董事会秘书列席会议。会议的召集、召开及表决程序 符合《中华人民共和国公司法》（以下简称"《公司法》"）等法律、法规、规范性 文件和《公司章程》的有关规定，会议合法有效。 二、监事会会议审议情况 与会监事认真审议，通过了如下议案： 筹资金的议案》 公 司以募集资金置换 预先投 入募投项目及 已支付发行费用的自 筹资金合 计 已支付发行费用的自筹资金金额为2,758.14万元（不含增值税）。监事会认为本次募 集资金置换事项符合《上市公司募集资金监管规则》《深圳证券交易所上市公司自律 监管指引第1号——主板上市公司规范运作》等相关规定的要求，不影响募集资金投 资计划的正常进行，也不存在变相改变募集资金用途的情形，募集资金置换 ...

目 录 一、以自筹资金预先投入募投项目及支付发行费用的鉴证报告…第 1—2 页 二、以自筹资金预先投入募投项目及支付发行费用的专项说明…第 3—4 页 关于江苏华辰变压器股份有限公司 以自筹资金预先投入募投项目及支付发行费用的 鉴证报告 天健审〔2025〕15917 号 江苏华辰变压器股份有限公司全体股东： 我们鉴证了后附的江苏华辰变压器股份有限公司（以下简称江苏华辰公司） 管理层编制的《以自筹资金预先投入募投项目及支付发行费用的专项说明》。 一、对报告使用者和使用目的的限定 江苏华辰公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司募集资金监管规则》（证监会公告〔2025〕10 号）和《上海证券交易所 上市公司自律监管指引第 1 号——规范运作（2025 年 5 月修订）》 （上证发〔2025〕 并保证其内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 三、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对江苏华辰公司管理层编制的上述 说明独立地提出鉴证结论。 第 1 页 共 4 页 四、工作概述 本鉴证报告仅供江苏华辰公司为以募集资金置换预先投入募投项目及支付 发行费用的自 ...

Core Viewpoint - Zhejiang Meilun Elevator Co., Ltd. has made significant decisions regarding the use of raised funds, including replacing self-raised funds and managing idle funds, which are expected to enhance financial efficiency and shareholder returns [2][3][5][7]. Fund Management - The company plans to use raised funds to replace self-raised funds amounting to RMB 75.27 million and issuance expenses of RMB 1.86 million, totaling RMB 77.13 million [2][3][6]. - The replacement of funds will occur within six months of the funds being received [3][6]. - The company intends to manage idle raised funds of up to RMB 150 million for cash management, ensuring it does not affect the normal investment plans [7][8]. Capital Changes - The company has approved a change in registered capital from RMB 307 million to RMB 349.05 million following a stock issuance of 42,049,469 shares at a price of RMB 5.66 per share [4][6]. - The updated capital structure will be reflected in the company's articles of association, which will be revised accordingly [4][6]. Financial Performance - As of August 5, 2025, Meilun Elevator's stock closed at RMB 9.01, marking a 3.8% increase with a trading volume of 139,100 lots and a turnover of RMB 123 million [1][2]. - The net inflow of main funds on that day was RMB 16.31 million, accounting for 13.27% of the total turnover [2][5].

证券代码：603321 证券简称：梅轮电梯 公告编号：2025-034 浙江梅轮电梯股份有限公司 第四届监事会第十六次会议决议公告 （五）本次会议由公司监事会主席朱虹女士主持，公司部分董事及高级管理人员列 席了会议。 二、监事会会议审议情况 资金的议案》 公司拟使用募集资金置换预先已投入募集资金投资项目的自筹资金的金额为人民 币 7526.68 万元，使用募集资金置换已支付发行费用的自筹资金的金额为人民币 185.85 万元，合计人民币 7712.53 万元。公司本次募集资金置换时间距离募集资金到账时间不 超过 6 个月，符合相关法规的要求。 具体内容详见公司于同日在指定信息披露媒体披露的《浙江梅轮电梯股份有限公司 关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告》（公告 编号：2025-035）。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 （一）浙江梅轮电梯股份有限公司（以下简称"公司"）第四届监事会第十六次会 议（以下简称"本次会议"）的召开符合《公司法》《公司章程》等相关 ...

证券代码：603321 证券简称：梅轮电梯 公告编号：2025-035 浙江梅轮电梯股份有限公司 关于使用募集资金置换预先投入募投项目 二、发行申请文件承诺募集资金投资项目情况 及已支付发行费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 浙江梅轮电梯股份有限公司（以下简称"公司"）拟使用募集资金置换预先 已投入募集资金投资项目的自筹资金的金额为人民币 7526.68 万元，使用募集资金置 换已支付发行费用的自筹资金的金额为人民币 185.85 万元，合计人民币 7712.53 万元， 公司本次募集资金置换时间距离募集资金到账时间不超过 6 个月，符合相关法规的要 求。 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江梅轮电梯股份有限公司向特定对象 发行股票注册的批复》（证监许可〔2025〕1405号），公司本次以简易程序向特定对象 发行人民币普通股（A股）股票42,049,469股，每股面值为人民币1.00元，每股发行价 格为人民币5.66元，此次发行募集资金总额为 ...

Summary of Key Points Core Viewpoint The company, Wuhu Berteli Automotive Safety Systems Co., Ltd., is utilizing raised funds to replace pre-invested self-raised funds and paid issuance expenses, following regulatory compliance and internal approvals [1][6][9]. Group 1: Fundraising Overview - The company issued 28,020,000 convertible bonds with a total fundraising amount of RMB 2,802,000,000, resulting in a net amount of RMB 2,789,650,905 after deducting issuance costs of RMB 12,349,094.60 [1][2]. - All raised funds are stored in a special account approved by the board of directors to ensure proper management and usage [2]. Group 2: Fund Allocation and Adjustments - The total planned investment for projects was RMB 336,949.05 million, with the adjusted amount for raised funds being RMB 278,965.09 million [2][3]. - Specific project funding adjustments include: - Electronic Mechanical Brake (EMB) project: adjusted from RMB 50,000.00 to RMB 22,645.00 million - High-strength aluminum alloy casting project: adjusted from RMB 35,000.00 to RMB 31,091.00 million - Working capital: adjusted from RMB 81,953.30 to RMB 80,718.39 million [2][3]. Group 3: Pre-Investment and Issuance Expenses - As of July 29, 2025, the company pre-invested RMB 71,662.13 million of self-raised funds into the projects [3][5]. - The total issuance expenses amounted to RMB 1,234.91 million, with RMB 314.75 million paid from self-raised funds [5][6]. Group 4: Compliance and Approval Process - The board of directors approved the use of raised funds to replace pre-invested self-raised funds and paid issuance expenses, totaling RMB 71,976.88 million [6][8]. - The monitoring committee confirmed that the procedures followed comply with relevant regulations and do not affect the normal progress of the fundraising projects [8][9]. - The sponsor institution verified that the replacement of funds aligns with the implementation plan and adheres to regulatory requirements [9].

重要内容提示： 证券代码：603939 证券简称：益丰药房 公告编号：2025-069 债券代码：113682 债券简称：益丰转债 益丰大药房连锁股份有限公司 关于使用自有资金支付募投项目部分款项并以募集资 金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 ?益丰大药房连锁股份有限公司（以下简称"公司"）拟在"益丰数字化平台 升级项目"（以下简称"数字化项目"）实施期间以不超过 705.00 万元募集资金等 额置换自有资金先行支付的相关支出，该部分等额置换资金视同募投项目使用资金。 ?本次募集资金等额置换的事项无需提交股东会审议。 公司于 2025 年 7 月 30 日召开第五届董事会第十九次会议和第五届监事会第十 三次会议审议通过了《关于使用自有资金支付募投项目部分款项并以募集资金等额 置换的议案》。公司监事会对此发表了明确同意的意见，保荐人对本事项出具了明 确同意的核查意见。现将有关情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意益丰大药房连锁股份有限公司向不特 定对象发行可 ...

Core Viewpoint - The company intends to use its own funds to pay for part of the investment project and subsequently replace it with raised funds, which is in compliance with regulatory requirements and aims to enhance the efficiency of fund utilization [1][5]. Fundraising Basic Situation - The company has received approval from the China Securities Regulatory Commission to issue convertible bonds, with net fundraising amounting to approximately 253.43 million yuan after deducting related expenses [1][2]. Investment Project Basic Situation - As of June 30, 2025, the total investment for the projects, including the Jiangsu Phase II, Hubei Pharmaceutical Sorting and Processing Center, and Hebei Pharmaceutical Warehouse, amounts to 253.43 million yuan, with 179.74 million yuan allocated from the raised funds [2]. Reasons for Using Own Funds - The company faces challenges in using raised funds directly for certain expenses, such as employee salaries and social insurance, which must be paid through the basic deposit account. Therefore, it plans to use up to 7.05 million yuan of its own funds for these payments and later replace them with raised funds [3][4]. Impact on the Company - The use of self-funds for project payments and subsequent replacement with raised funds is expected to improve fund utilization efficiency and ensure the smooth progress of investment projects without affecting the normal implementation of the projects [4][5]. Review Procedures and Opinions - The company's board and supervisory committee have approved the proposal to use self-funds for the investment project, confirming that this action does not harm the interests of the company or its shareholders and complies with relevant regulations [5].

证券代码：002049 证券简称：紫光国微 公告编号：2025-071 债券代码：127038 债券简称：国微转债 紫光国芯微电子股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 紫光国芯微电子股份有限公司监事会 有资金支付募投项目部分款项并以募集资金等额置换的议案》，并发表审核意见 如下： 经审核，监事会认为：公司使用自有资金支付募投项目部分款项并以募集资 金等额置换事项履行了必要的决策程序，制定了相应的操作流程，不会影响募投 项目的正常实施，不存在变相改变募集资金投向和损害股东利益的情形，也不存 在违反《上市公司募集资金监管规则》《深圳证券交易所上市公司自律监管指引 第 1 号——主板上市公司规范运作》等法律、法规、规章及规范性文件的情形。 具体内容详见公司于同日在《中国证券报》及巨潮资讯网 （http://www.cninfo.com.cn）上披露的《关于使用自有资金支付募投项目部分 款项并以募集资金等额置换的公告》。 特此公告。 紫光国芯微电子股份有限公司（以下简称"公司"）第八届监事会第十六次 会议通知于 2025 年 7 月 25 日以 ...

Core Viewpoint - Beijing Yitang Semiconductor Technology Co., Ltd. plans to use raised funds amounting to CNY 2,097,556,497.48 to replace self-raised funds previously invested in fundraising projects and paid issuance expenses, in compliance with relevant regulations and within six months of the funds being received [1][5][7] Summary of Fundraising Situation - The company raised a total of CNY 2,342,867,334.94 through its initial public offering (IPO) of 295,560,000 shares at a price of CNY 8.45 per share, as confirmed by KPMG Huazhen [1][2] - The raised funds are managed in a dedicated account, with a tripartite supervision agreement signed with the sponsor and the bank [1] Summary of Investment Projects - The net amount raised is lower than the initially disclosed amount in the prospectus, leading to adjustments in the investment amounts for the fundraising projects [2] - The adjusted investment amounts for the projects are as follows: - Yitang Semiconductor Integrated Circuit Equipment R&D Manufacturing Service Center: CNY 250,000,000 - Yitang Semiconductor High-end Integrated Circuit Equipment R&D Project: CNY 234,286,730 - Total adjusted investment: CNY 234,286,730 [2] Summary of Self-raised Funds and Replacement Arrangement - The actual investment amount from self-raised funds prior to the IPO was CNY 2,042,867,334.94, which the company plans to replace with the raised funds [4][6] - The total amount for replacing self-raised funds and issuance expenses is CNY 2,097,556,497.48, which includes CNY 54,689,162.54 for issuance expenses [4][5] Review Procedures - The board and supervisory committee approved the proposal to use raised funds for replacement on July 25, 2025, confirming compliance with regulatory requirements [4][6][7] - The supervisory committee and KPMG Huazhen provided opinions supporting the replacement, affirming that it does not affect the normal progress of fundraising projects or harm shareholder interests [6][7]